placeUnited States
Contact Us
Medtronic / Covidien Products / Remote Monitoring / Healthcast™ Intelligent Patient Manager / BioButton®* Multi-parameter Wearable

Overview

Helping you prioritize. When everything is a priority.

You have an unwavering commitment to delivering quality of care to all patients. But with staffing shortages and clinician burnout, that task has become more challenging.

Part of the Healthcast™ intelligent patient manager, a portfolio of remote monitoring and connectivity solutions, the BioButton® multi-parameter wearable† is designed to empower clinicians by helping simplify their workflow and reduce burnout, so that they can prioritize care for patients who need it the most.

Built for continuous vital sign monitoring of skin temperature, resting respiratory rate, and resting heart rate, along with a broad range of other biometrics, the BioButton® wearable helps you stay in sync with every patient’s vital sign data and responding to their changing needs, no matter where they are, in-hospital or hospital-to-home.

It’s our commitment to always look out for patients — and always look out for you.

Continuous remote patient monitoring — connecting all the right points

Reduce burnout, empower clinicians‡

  • Reduced need for manual vital sign collection1
  • Decreased manual documentation time1
  • Clinically actionable notifications without alarm fatigue2

Improve patient satisfaction‡

  • Fewer nighttime spot checks that wake patients3
  • Eliminating the need to disconnect from a bedside monitor for certain parameters

Improve outcomes in hospital‡

Using continuous wearable remote patient monitoring on the medical-surgical floor can enable earlier intervention through earlier identification of adverse patient physiologic trends, which can lead to:
 
  • Shorter hospital length of stay4
  • Fewer unplanned ICU admissions5,6,7
  • Fewer rapid response team activations3,5,7
  • Decrease in complication rates6

Improve outcomes at home‡

Remote monitoring of patients once they are discharged can help clinicians address and treat issues quickly, which may:

  • Reduce mortality8
  • Reduce unplanned readmissions, especially on patients with chronic illness such as COPD or CHF8



‡ Based on studies done on devices using same or some of the same monitoring parameters as the BioButton®* multi-paramter wearable

Features

  • Small, discreet, and simple-to-apply, self-adhesive device
  • Non-invasive, remote patient monitoring solution that’s worn on the patient’s upper left chest
  • Up to 16-day continuous battery life§
  • Tracks and captures 1,440 vital sign measurements per day, including clinically relevant parameters of skin temperature, respiratory rate at rest, and heart rate at rest
  • Personalized baseline alerts help reducing clinical alarm fatigue
  • Integrate with existing EMR systems in hospitals
  • Configurable acute and post-acute modes
  • Secure, purpose-built BioHub™ platform or BioMobile™ app, along with BioButton®* multi-parameter wearable device, allow clinicians to monitor vital signs of patients who have been discharged from the hospital
  • BioButton®* device and its supporting systems are HIPAA-compliant and adhere to strict privacy and security standards

§ BioButton®* device in post-acute configuration mode

Resources

  • Data from the BioButton® multi-parameter wearable should not be used as the sole basis for diagnosis or therapy and are intended only as adjuncts to patient assessment.

  • * BioIntelliSense™, BioButton® and the BioIntelliSense logo are trademarks of BioIntelliSense, Inc.

  • † The BioButton® multi-parameter wearable device is not intended for critical care monitoring.

  • 1. Bellomo R, Ackerman M, Bailey M, et al. A controlled trial of electronic automated advisory vital signs monitoring in general hospital wards. Crit Care Med. 2012;40(8):2,349–2,361.

  • 2. Leenen JPL, Rasing HJM, van Dijk JD, Kalkman CJ, Schoonhoven L, Patijn GA. Feasibility of wireless continuous monitoring of vital signs without using alarms on a general surgical ward: A mixed methods study. PLOS One. 2022;17(3):e0265435.

  • 3. Stellpflug C, Pierson L, Roloff D, et al. Continuous physiological monitoring improves patient outcomes. Am J Nurs. 2021;121(4):40–46.

  • 4. Downey C, Randell R, Brown J, Jayne DG. Continuous versus intermittent vital signs monitoring using a wearable, wireless patch in patients admitted to surgical wards: pilot cluster randomized controlled trial. J Med Internet Res. 2018;20(12):e10802.

  • 5. Eddahchouri Y, Peelen RV, Koeneman M, Touw HRW, van Goor H, Bredie SJH. Effect of continuous wireless vital sign monitoring on unplanned ICU admissions and rapid response team calls: a before-and-after study. Br J Anaesth. May 2022;128(5):857-863.

  • 6. Verrillo SC, Cvach M, Hudson KW, Winters BD. Using Continuous Vital Sign Monitoring to Detect Early Deterioration in Adult Postoperative Inpatients. J Nurs Care Qual. Apr/Jun 2019;34(2):107-113.

  • 7. Weller RS, Foard KL, Harwood TN. Evaluation of a wireless, portable, wearable multi-parameter vital signs monitor in hospitalized neurological and neurosurgical patients. J Clin Monit Comput. Oct 2018;32(5):945-951.

  • 8. Hamza M, Alsma J, Kellett J, Brabrand M, Christensen EF, Cooksley T, et al. Can vital signs recorded in patients' homes aid decision making in emergency care? A Scoping Review. Resusc Plus. 2021;6:100116.

Corporate Resources
Medical Surgical Portfolio
Patient Resources
Additional Resources
Contact Us
Operational Headquarters

710 Medtronic Parkway

Minneapolis, MN

55432-5604

USA

©2024 Medtronic